Suping ZHANG: Clinical Trials

1 trial sponsored by Suping ZHANG, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 41Recruiting 1

Follow Suping ZHANG: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
Blinatumomab - Acute B-cell Lymphoblastic Leukemia
Phase 4RecruitingSuping ZHANG602023-09-012024-04-01

Conditions studied

Recurrence (1)

Interventions

blinatumomab (1)

Countries

China (1)

Results publications

PMID 41671463